GSK to produce 1 billion doses of vaccine efficacy boosters

0
0

Britain’s GlaxoSmithKline laid out plans on Thursday to produce 1 billion doses of vaccine efficacy boosters, or adjuvants, next year as the race to develop and produce a successful solution to the coronavirus crisis heats up. The world’s largest vaccine maker said it was in talks with governments to back a manufacturing expansion that would help to scale up production of future vaccines for COVID-19, the disease caused by the novel coronavirus.

NO COMMENTS